Lessons from the second wave of coronavirus pandemic

By Kiran Mazumdar-Shaw The second Covid-19 wave has hit India, and hit it hard. Record jumps in coronavirus infections on a daily basis have pushed health infrastructure to the brink in several states. While patients are scrambling to secure hospital beds, hospitals are running out of oxygen supplies and critical anti-Covid-19 drugs along with medical … Continue reading Lessons from the second wave of coronavirus pandemic

India Racing Against Time, Needs to Open Up Vaccines for Young, Mobile Workforce

By Kiran Mazumdar-Shaw India is witnessing a second wave of novel coronavirus infections with the country now adding over 100,000 cases per day. Maharashtra, Karnataka, Kerala, Tamil Nadu, Andhra Pradesh, Chhattisgarh and Punjab have emerged as COVID-19 hotspots. To stem the next wave, India needs to act with urgency and ramp up the pace of … Continue reading India Racing Against Time, Needs to Open Up Vaccines for Young, Mobile Workforce

How India Should Be Rebranded for Post-Covid Global Leadership

By Kiran Mazumdar-Shaw The Covid-19 pandemic is an inflection point for India to introspect on its global leadership potential. Despite the economic devastation caused by the virus, India’s agility in pivoting its resources to respond to the crisis has made the country a global outlier. With 1.3 billion people, we have seen about 12 million … Continue reading How India Should Be Rebranded for Post-Covid Global Leadership

Women in Leadership: Kiran Mazumdar-Shaw & Debjani Ghosh Engage in a Special Fireside Chat

To celebrate International Women’s Day 2021, Biocon brought together two of India’s most successful women role models who are an inspiration for today’s generation of girls to become tomorrow’s business leaders. Biocon Executive Chairperson Kiran Mazumdar-Shaw and NASSCOM President Debjani Ghosh participated in a very engaging virtual Fireside Chat on the topic of ‘Women in … Continue reading Women in Leadership: Kiran Mazumdar-Shaw & Debjani Ghosh Engage in a Special Fireside Chat

We Need More Indian Women to Make a Mark in Science

By Kiran Mazumdar-Shaw “A ship in port is safe, but that's not what ships are built for,” said Grace Hopper (1906–1992), one of the first programmers in the history of computers. Her belief that programming languages should be as easily understood as English was highly influential on the development of COBOL, one of the first computer … Continue reading We Need More Indian Women to Make a Mark in Science

A Reassuring Budget Focused on Growth, Investment & Jobs

By Kiran Mazumdar-Shaw, Executive Chairperson, Biocon It was very encouraging to see such a pragmatic, growth-focused budget that addresses the key need to boost economic recovery in the aftermath of the COVID-19 impact. This has been reflected in the market cheer following the announcement. The budget covers the major segments which needed redressal with big … Continue reading A Reassuring Budget Focused on Growth, Investment & Jobs

Budget Push can Transform ASHA Workers from Health Activists to Digital Health Agents to deliver on NDHM

By Kiran Mazumdar-Shaw Chairperson, Biocon Group and member of The Lancet Citizen’s Commission on Re-imagining India’s Health System Technology can enable India to leapfrog into an advanced healthcare system that fulfils the vision of the national health policy of promoting wellness, universal access and affordable care for all Indians. The National Digital Health Mission (NDHM) … Continue reading Budget Push can Transform ASHA Workers from Health Activists to Digital Health Agents to deliver on NDHM

Economic Liberalisation and the Changing Face of Healthcare in India

By Kiran Mazumdar-Shaw, Executive Chairperson, Biocon & Biocon Biologics India’s healthcare standards have significantly improved over the past decades. Life expectancy has doubled from 35 years in 1950 to 70 years today. Most infectious diseases have been brought under control. Many key indicators of rural healthcare have also improved: Infant Mortality Rate (IMR) has reduced … Continue reading Economic Liberalisation and the Changing Face of Healthcare in India

Indian regulator has granted Emergency Approval to Covaxin, Covishield based on strong scientific judgment.

India’s health regulator Drugs Controller General of India (DCGI) has granted Emergency Use Authorization (EUA) to two vaccines, Covaxin andCovishield , to fight the COVID-19 pandemic. Covaxin has been developed by Bharat Biotech in collaboration with the Indian Council for Medical Research (ICMR) and National Institute of Virology (NIV). Covishield has been developed by Oxford … Continue reading Indian regulator has granted Emergency Approval to Covaxin, Covishield based on strong scientific judgment.

India needs to inoculate a million people a day against COVID-19

India's health regulator Drugs Controller General of India (DCGI) has granted permission to two vaccines, Covishield and Covaxin, for "restricted use" in an emergency situation to fight the COVID-19 pandemic. Covishield has been developed by Oxford University scientists in collaboration with pharmaceutical company AstraZeneca. In India, its trial was undertaken by the Serum Institute of … Continue reading India needs to inoculate a million people a day against COVID-19